Works matching DE "DARBEPOETIN alfa"
Results: 84
Pharmacological correction of morphofunctional retinal injury using 11-amino acid fragment of darbepoetin in the experiment.
- Published in:
- Research Results in Pharmacology, 2019, v. 5, n. 3, p. 43, doi. 10.3897/rrpharmacology.5.38730
- By:
- Publication type:
- Article
Correction of ischemic optic neuropathy in rats by carbamylated darbepoetin.
- Published in:
- Research Results in Pharmacology, 2018, v. 4, n. 1, p. 43, doi. 10.3897/rrpharmacology.4.25262
- By:
- Publication type:
- Article
SEARCH OF NEW PHARMACEUTICALS ON THE BASIS OF DARBEPOETIN IN THE TREATMENT OF ISCHEMIC STROKE (REVIEW OF LITERATURE).
- Published in:
- Research Results in Pharmacology, 2017, v. 3, n. 1, p. 125, doi. 10.18413/2500-235X-2017-3-1-125-136
- By:
- Publication type:
- Article
Late-onset Erythropoietic Protoporphyria Associated with Myelodysplastic Syndrome Treated with Azacitidine.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Switch from epoetin to darbepoetin alfa in hemodialysis: dose equivalence and hemoglobin stability.
- Published in:
- International Journal of Nephrology & Renovascular Disease, 2014, v. 7, p. 353, doi. 10.2147/IJNRD.S61895
- By:
- Publication type:
- Article
Reticulocyte dynamic and hemoglobin variability in hemodialysis patients treated with Darbepoetin alfa and C.E.R.A.: a randomized controlled trial.
- Published in:
- BMC Nephrology, 2013, v. 14, n. 1, p. 1, doi. 10.1186/1471-2369-14-157
- By:
- Publication type:
- Article
Pre-Emptive Replacement of Water Treatment Components Improves Responsiveness to Erythropoiesis-Stimulating Agents in Maintenance Haemodialysis Patients: A Quality Improvement Report.
- Published in:
- Blood Purification, 2014, v. 36, n. 3/4, p. 265, doi. 10.1159/000355013
- By:
- Publication type:
- Article
Conversion from Epoetin and Darbepoetin to C.E.R.A. in Non-Dialysis CKD Patients: A Multicenter Italian Prospective Study in Nephrology Practice.
- Published in:
- Blood Purification, 2013, v. 36, n. 2, p. 69, doi. 10.1159/000353607
- By:
- Publication type:
- Article
Higher Doses of Erythropoietin-Stimulating Agents and Hyporesponsiveness to Their Effects Are Associated with Increased Mortality among Prevalent Hemodialysis Patients.
- Published in:
- Blood Purification, 2013, v. 36, n. 1, p. 29, doi. 10.1159/000350583
- By:
- Publication type:
- Article
Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of <9 g/dL versus 9 to <10 g/dL versus ≥10 g/dL: an exploratory analysis of a phase 3 trial.
- Published in:
- Medical Oncology, 2012, v. 29, n. 3, p. 2291, doi. 10.1007/s12032-011-0103-x
- By:
- Publication type:
- Article
Hemoglobin levels and quality of life in patients with symptomatic chemotherapy-induced anemia: the eAQUA study.
- Published in:
- Cancer Management & Research, 2016, v. 8, p. 1, doi. 10.2147/CMAR.S88110
- By:
- Publication type:
- Article
Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 5, p. 621, doi. 10.1007/s00277-013-1686-4
- By:
- Publication type:
- Article
Erratum to: High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM.
- Published in:
- 2013
- By:
- Publication type:
- Correction Notice
Extended dosing intervals with erythropoiesis-stimulating agents in chronic kidney disease: a review of clinical data.
- Published in:
- Nephrology Dialysis Transplantation, 2007, v. 22, n. suppl_4, p. iv19, doi. 10.1093/ndt/gfm162
- By:
- Publication type:
- Article
Pharmacology of darbepoetin alfa.
- Published in:
- Nephrology Dialysis Transplantation, 2007, v. 22, n. suppl_4, p. iv2, doi. 10.1093/ndt/gfm160
- By:
- Publication type:
- Article
Foreword.
- Published in:
- Nephrology Dialysis Transplantation, 2007, v. 22, n. suppl_4, p. iv1, doi. 10.1093/ndt/gfm159
- By:
- Publication type:
- Article
Efficacy of once or twice weekly administration of epoetin κ in patients receiving hemodialysis: A retrospective study.
- Published in:
- Experimental & Therapeutic Medicine, 2014, v. 7, n. 1, p. 27, doi. 10.3892/etm.2013.1384
- By:
- Publication type:
- Article
Antioxidant and antiapoptotic effects of darbepoetin-α against traumatic brain injury in rats.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney disease.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF).
- Published in:
- European Journal of Heart Failure, 2013, v. 15, n. 3, p. 334, doi. 10.1093/eurjhf/hfs204
- By:
- Publication type:
- Article
Triple Therapy with Darbepoetin Alfa, Idebenone, and Riboflavin in Friedreich's Ataxia: an Open-Label Trial.
- Published in:
- Cerebellum, 2013, v. 12, n. 5, p. 713, doi. 10.1007/s12311-013-0482-y
- By:
- Publication type:
- Article
Managing chemotherapy induced anemia with darbepoetin alfa and other erythropoiesis stimulating agents: a nurse's perspective.
- Published in:
- Nursing: Research & Reviews, 2013, v. 3, p. 155, doi. 10.2147/NRR.S49399
- By:
- Publication type:
- Article
Efficacy and safety of darbepoetin alpha in patients with myelodysplastic syndromes: a systematic review and meta-analysis.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 5, p. 730, doi. 10.1111/bjh.14116
- By:
- Publication type:
- Article
Oral sucrosomial iron versus intravenous iron in anemic cancer patients without iron deficiency receiving darbepoetin alfa: a pilot study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Synchronization of administrations of chemotherapy and erythropoiesis-stimulating agents and frequency of associated healthcare visits.
- Published in:
- Supportive Care in Cancer, 2013, v. 21, n. 11, p. 2957, doi. 10.1007/s00520-013-1830-7
- By:
- Publication type:
- Article
Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe.
- Published in:
- Supportive Care in Cancer, 2013, v. 21, n. 2, p. 485, doi. 10.1007/s00520-012-1538-0
- By:
- Publication type:
- Article
The efficiency of fatty acids, N-acetyl-D-mannosamine, and N-acetylneuraminic acid for a change in the sialylation profile of recombinant darbepoetin alfa in CHO cell culture.
- Published in:
- Applied Biochemistry & Microbiology, 2015, v. 51, n. 8, p. 827, doi. 10.1134/S0003683815080049
- By:
- Publication type:
- Article
Optimization of genetic constructs for high-level expression of the darbepoetin gene in mammalian cells.
- Published in:
- Applied Biochemistry & Microbiology, 2014, v. 50, n. 9, p. 802, doi. 10.1134/S0003683814090051
- By:
- Publication type:
- Article
Design of a stable cell line producing recombinant darbepoetin alpha based on CHO cells.
- Published in:
- Applied Biochemistry & Microbiology, 2014, v. 50, n. 9, p. 812, doi. 10.1134/S0003683814090063
- By:
- Publication type:
- Article
Results of darbepoetin alfa treatment of anaemia in chemotherapy-receiving breast cancer patients: a single-centre retrospective observational study.
- Published in:
- Oncology in Clinical Practice (2450-1654), 2021, v. 17, n. 6, p. 237, doi. 10.5603/OCP.2020.0048
- By:
- Publication type:
- Article
Effects of long- and short-term darbepoetin-α treatment on oxidative stress, inflammation and endothelial injury in ApoE knockout mice.
- Published in:
- Advances in Clinical & Experimental Medicine, 2017, v. 26, n. 4, p. 635, doi. 10.17219/acem/62834
- By:
- Publication type:
- Article
A Comparative Study of the Hemoglobin-Maintaining Effects Between Epoetin-β Pegol and Darbepoetin-α in Patients with Chronic Kidney Disease During 3 Months Before Dialysis Initiation.
- Published in:
- Drugs in R&D, 2017, v. 17, n. 3, p. 389, doi. 10.1007/s40268-017-0188-6
- By:
- Publication type:
- Article
Dose equivalence between continuous erythropoietin receptor activator (CERA), Darbepoetin and Epoetin in patients with advanced chronic kidney disease.
- Published in:
- Hippokratia, 2014, v. 18, n. 4, p. 315
- By:
- Publication type:
- Article
Erythropoiesis stimulating agents: approaches to modulate activity.
- Published in:
- Biologics: Targets & Therapy, 2013, v. 7, p. 161, doi. 10.2147/BTT.S45971
- By:
- Publication type:
- Article
Maintenance of target hemoglobin level in stable hemodialysis patients constitutes a theoretical task: a historical prospective study: New strategies to prevent cardiovascular risk in chronic kidney disease.
- Published in:
- Kidney International, 2008, v. 74, p. S82, doi. 10.1038/ki.2008.524
- By:
- Publication type:
- Article
Darbepoetin alfa: A new therapeutic agent for renal anemia.
- Published in:
- Kidney International, 2002, v. 61, p. S55, doi. 10.1046/j.1523-1755.61.s80.11.x
- By:
- Publication type:
- Article
Identification of the long-acting erythropoiesis-stimulating agent darbepoetin alfa in human urine by liquid chromatography-tandem mass spectrometry.
- Published in:
- Analytical & Bioanalytical Chemistry, 2014, v. 406, n. 5, p. 1317, doi. 10.1007/s00216-013-6836-y
- By:
- Publication type:
- Article
Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial).
- Published in:
- Clinical & Experimental Nephrology, 2018, v. 22, n. 1, p. 78, doi. 10.1007/s10157-017-1427-4
- By:
- Publication type:
- Article
Rationale and study design of a randomized controlled trial to assess the effects of maintaining hemoglobin levels using darbepoetin alfa on prevention of development of end-stage kidney disease in non-diabetic CKD patients (PREDICT Trial).
- Published in:
- Clinical & Experimental Nephrology, 2016, v. 20, n. 1, p. 71, doi. 10.1007/s10157-015-1133-z
- By:
- Publication type:
- Article
Pharmacokinetics of darbepoetin alfa after single, intravenous or subcutaneous administration in Japanese pediatric patients with chronic kidney disease.
- Published in:
- Clinical & Experimental Nephrology, 2014, v. 18, n. 6, p. 932, doi. 10.1007/s10157-014-0936-7
- By:
- Publication type:
- Article
Effects of three kinds of erythropoiesis-stimulating agents on renal anemia in Japanese non-dialysis chronic kidney disease patients.
- Published in:
- Clinical & Experimental Nephrology, 2014, v. 18, n. 5, p. 755, doi. 10.1007/s10157-013-0919-0
- By:
- Publication type:
- Article
Efficacy and safety of darbepoetin alfa for anemia in children with chronic kidney disease: a multicenter prospective study in Japan.
- Published in:
- Clinical & Experimental Nephrology, 2014, v. 18, n. 4, p. 634, doi. 10.1007/s10157-013-0859-8
- By:
- Publication type:
- Article
Darbepoetin alfa for the treatment of anemia in children undergoing peritoneal dialysis: a multicenter prospective study in Japan.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 4, p. 582, doi. 10.1007/s10157-012-0714-3
- By:
- Publication type:
- Article
Different administration schedules of darbepoetin alfa affect oxidized and reduced glutathione levels to a similar extent in 5/6 nephrectomized rats.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 4, p. 569, doi. 10.1007/s10157-012-0749-5
- By:
- Publication type:
- Article
Erratum.
- Published in:
- 2016
- Publication type:
- Correction Notice
Darbepoetin-α Promotes Cell Proliferation in Established Extrahepatic Colorectal Tumors after Major Hepatectomy.
- Published in:
- European Surgical Research, 2016, v. 56, n. 1/2, p. 49, doi. 10.1159/000442384
- By:
- Publication type:
- Article
Darbepoetin-α Accelerates Neovascularization and Engraftment of Extrahepatic Colorectal Metastases.
- Published in:
- European Surgical Research, 2014, v. 53, n. 1-4, p. 25, doi. 10.1159/000364944
- By:
- Publication type:
- Article
Outcomes in patients with chronic kidney disease not on dialysis receiving extended dosing regimens of darbepoetin alfa: long-term results of the EXTEND observational cohort study.
- Published in:
- Nephrology Dialysis Transplantation, 2016, v. 31, n. 12, p. 2073, doi. 10.1093/ndt/gfw047
- By:
- Publication type:
- Article
DIALYSIS ANAEMIA.
- Published in:
- Nephrology Dialysis Transplantation, 2014, v. 29, n. suppl_3, p. iii491, doi. 10.1093/ndt/gfu176
- Publication type:
- Article